Degree in Medicine and Surgery. Completed in 2015

Master's Degree in Uro-Oncology, Universidad Cardenal Herrera (CEU)

Master's Degree in Multidisciplinary Management of Prostate Cancer, Universidad Autónoma de Madrid

Residency in Urology (MIR) at Hospital Universitario Virgen de Valme (2016-2021)

Consultant Urologist at Fundación Jiménez Díaz University Hospital (2021-present)

PhD candidate, Official Doctoral Program, Universidad Autónoma de Madrid

Sub-Investigator in Clinical Trial ALBAN: An open label, randomized, phase III trial, evaluating efficacy of Atezolizumab in addition to one year BCG (Bacillus CaLmetteGuerin) bladder instillation in BCG-naive patients with high-risk non-muscle invasive Bladder cANcer UNICANCER Group Tumor: GETUG / AFU. 2022-01/01/2027.

Sub-Investigator in Clinical Trial ENCORE-01: Phase IIb Clinical Trial: Treatment of high-risk non-muscle infiltrating bladder tumors with IMUNO BCG Moreau RJ as prophylaxis for recurrence and progression Biofabri/FIU.

Sub-Investigator in Clinical Trial ENVISION: A Phase 3, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of UGN-102 as Primary Chemoablative Therapy in Patients with Low Grade (LG) Non-Muscle-Invasive Bladder Cancer (NMIBC) at Intermediate Risk (IR) of Recurrence UroGen Pharma Ltd. 2022-01/01/2027.

Sub-Investigator in Clinical Trial URANUS TRIAL: Neo-adjuvant versus Adjuvant chemotherapy in Upper tract Urothelial Carcinoma: A feasibility phase II randomizec clinical Trial EUOG (European Uro-oncology Group).

Clínico Colaborador Docente en Facultad de Medicina de la Universidad Autónoma de Madrid

Profesor Facultad de Medicina de la Universiad Alfonso X